Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Accumulated Depreciation (2019)

Marker Therapeutics (MRKR) has disclosed Accumulated Depreciation for 1 consecutive years, with $105000.0 as the latest value for Q4 2019.

  • Quarterly Accumulated Depreciation changed N/A to $105000.0 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $105000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $105000.0 for FY2019, N/A changed from the prior year.
  • Accumulated Depreciation for Q4 2019 was $105000.0 at Marker Therapeutics, up from $71000.0 in the prior quarter.
  • The five-year high for Accumulated Depreciation was $105000.0 in Q4 2019, with the low at $40000.0 in Q2 2019.